Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Actigall
Active Ingredient(s): Ursodeoxycholic acid 300mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharmaceuticals Corporation, Suffern, New York, United States of America
Note: This consent is valid for 2 years from 7 September 2001.
Product: Avonex
Active Ingredient(s): Interferon beta-1a 30µg
Dosage Form: Powder for injection
New Zealand Sponsor: Biogen Australia Pty Limited
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Pierre Fabre Medicament Production, Idron, France
Note: This consent is valid for 2 years from 30 October 2001.
Dated this 22nd day of August 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).